Regulation of parathyroid function by the amyloid precursor protein
Regulation of parathyroid function by the amyloid precursor protein
批准号:
10225816
负责人:
Wenhan Chang
金额:
$28.26万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-01 至 2023-01-31
关键词:
AblationAddressAffectAgeAgingAmyloidAmyloid Beta A4 Precursor ProteinAmyloid beta-ProteinAmyloid beta-Protein PrecursorAttenuatedBehaviorBindingBinding ProteinsBiochemicalBiological AssayBiological ModelsCalciumCalcium SignalingCalcium-Sensing ReceptorsCell Culture TechniquesCellsChronicCleaved cellClinicalComplexCouplingDataDefectDiseaseDoseElderlyEndocrineEnzyme-Linked Immunosorbent AssayEvaluationFailureFeedbackFosteringFunctional disorderG-Protein-Coupled ReceptorsGABA-B ReceptorGTP-Binding ProteinsGenetic ModelsGlandHealthHeterogeneityHomeostasisHormonalHormone secretionHumanHypercalcemiaHyperparathyroidismHypoparathyroidismImpaired cognitionIn SituIn VitroIncidenceIndividualIntestinesKidneyKnock-outKnockout MiceLigandsLinkLoxP-flanked alleleMass Spectrum AnalysisMediatingMineralsMolecularMusMutationNeuronsNormal tissue morphologyOrganOrgan Culture TechniquesOutcomePTH geneParathyroid AdenomaParathyroid NeoplasmsParathyroid glandPathologicPathway interactionsPatientsPeptide HydrolasesPeptidesPhenotypePhysiologicalPopulationPost-Translational Protein ProcessingProductionPropertyProteinsPublishingRNAReceptor SignalingRegulationReportingRoleSeriesSerumSignal TransductionSubgroupSystemTestingTherapeutic InterventionTimeTissuesUp-RegulationVariantVulnerable PopulationsWorkadenomaage relatedalpha secretaseamyloid peptideamyloid precursor protein processingattenuationbasebehavioral responsebeta secretasebonebone masscalcium absorptioncalcium metabolismcomparativeexperimental studyfracture riskgamma secretasegamma-Aminobutyric Acidin vivoinnovationmicroCTmouse modelneoplasticnovelparacrinereceptorresponsesecretaseskeletaltranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Primary hyperparathyroidism (PHPT) is a common endocrine neoplastic disorder that predominantly occurs in the elderly. PHPT affects 15 to 30 individuals per 100,000 in the U.S., an overall incidence that has been steadily rising as the nation’s mean population ages. The disease is biochemically defined by constitutively elevated secretion of parathyroid hormone (PTH) from neoplastic parathyroid tissue, leading to chronic hypercalcemia and a spectrum of clinical sequelae including bone mass attrition and increased fracture risk. While the central physiological deficit in PHPT – the failure to maintain calcium homeostasis – is well recognized, the underlying molecular mechanisms that drive this systemic dysfunction have not been fully characterized. A major limitation to studying calcium sensing in normal and neoplastic parathyroid tissue has been the lack of experimentally tractable model systems that can faithfully reproduce the dynamic calcium response behaviors of the intact organ. To address this, our group has developed a series of ex vivo intact tissue assays that allow interrogative assessment of parathyroid gland function in response to dynamic changes in ambient calcium concentration. Through comparative assessment of normal and neoplastic human parathyroid tissue, we found molecular and biochemical functional heterogeneity among parathyroid adenomas that correlated to phenotypic variations in clinical presentation. In parallel, using a series of murine genetic models our group has recently demonstrated that heterocomplex formation between the calcium sensing receptor (CaSR) and the metabotropic GABAB1 receptor (GABAB1R) can attenuate calcium responsiveness, uncoupling PTH secretion from ambient calcium sensing. The abundance of GABAB1R/CaSR complexes was found to be increased in parathyroid adenomas from patients with PHPT, suggesting that upregulation of GABAB1R/CaSR heterodimer formation could contribute to the attenuation of calcium sensing in neoplastic parathyroid tissue. Indeed, based on recently published work in neuronal systems reporting that various cleaved peptides of the amyloid precursor protein (APP) bind and activate GABAB1R, we have found that tonic secretion of PTH by murine parathyroid tissue is stimulated by co-incubation with b-amyloid (Ab), a peptide cleavage product of APP. We further showed robust expression of APP and all 3 key secretases involved in cleavage of APP-related peptides (sAPPa, sAPPb, and Ab) in human parathyroid adenomas and murine parathyroid glands, implicating a novel paracrine mechanism that may foster functional heterogeneity in parathyroid adenomas. We propose to delineate this mechanism by (1) quantitating the expression of the various APP-derived peptides and determining their impact on calcium signaling and PTH secretion in normal and PHPT adenoma human parathyroid tissue; and (2) investigating the effects of parathyroid-specific APP knockout on mineral, skeletal, and hormonal homeostasis in vivo. The discovery of this entirely novel signaling axis represents a provocative new conceptual pathway potentially linking age-dependent post-translational processing of APP to the increased incidence of PHPT in the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vitamin D and beta-amyloid signaling in hyperparathyroidism
-
批准号:10668177
-
项目类别:
-
资助金额:$227.06万
-
财政年份:2023
-
负责人:Wenhan Chang
-
依托单位:
ShEEP Request for NanoString GeoMx Digital Spatial Profiling System
-
批准号:10741001
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Wenhan Chang
-
依托单位:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
-
批准号:10365254
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Wenhan Chang
-
依托单位:
Regulation of parathyroid function by the amyloid precursor protein
-
批准号:10398252
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2021
-
负责人:Wenhan Chang
-
依托单位:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
-
批准号:10531570
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Wenhan Chang
-
依托单位:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
-
批准号:10468008
-
项目类别:
-
资助金额:$43.52万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of PTH secretion by TRPC1
-
批准号:10366048
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of PTH secretion by TRPC1
-
批准号:9902425
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
-
批准号:10693870
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
-
批准号:10222663
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10515310
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10293574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of PTH secretion by TRPC1
-
批准号:10132314
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of PTH secretion by TRPC1
-
批准号:9764726
-
项目类别:
-
资助金额:$53.04万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
ShEEP Equipment Request for GeoMx™ Digital Spatial Profiler System
-
批准号:9906020
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
-
批准号:9809393
-
项目类别:
-
资助金额:$46.98万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10047236
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
-
批准号:10016313
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
ShEEP Equipment Request for nCounter Max Analysis System
-
批准号:9796399
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Wenhan Chang
-
依托单位:
A novel treatment for bone fracture repair
-
批准号:9442568
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Wenhan Chang
-
依托单位:
海外基金